Company: CRL
Filing Date: 2025-04-02
Form Type: DEF 14A
Source: 0001104659-25-030908
Chunk: 99

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-04-02
Form: DEF 14A
Chunk 99
---
 Paid” but do not necessarily reflect cash or equity value transferred to the executive outright.

​

(2)

For 2020 through 2022, our named executives were: Mr. Foster, Mr. David Smith (former Chief Financial Officer), Mr. Barbo (former Corporate Executive Vice President and Chief Commercial Officer), Ms. Girshick and Mr. LaPlume. Ms. Peasebecame a named executive in 2022 when she assumed the role of Chief Financial Officer. For 2023, our named executive officers are: Mr. Foster, Ms. Pease, Mr. Barbo, Ms. Girshick and Mr. LaPlume. For 2024, our named executive officers are: Mr. Foster, Ms. Pease, Ms. Creamer, Ms. Girshick and Mr. LaPlume.

​

(3)

TSR was measured for 2020 for the period from December 27, 2019 to December 24, 2020; for 2021 for the period from December 27, 2019 to December 23, 2021; for 2022 for the period from December 27,

**72

2019 to December 30, 2022; for 2023 for the period from January 2, 2023 to December 29, 2023; and for 2024 for the period of January 2, 2024 to December 27, 2024. The peer group is the S&P 500 Health Care Index. (4) The table reflects net income on a GAAP basis. On a non-GAAP basis, net income for fiscal 2024 was $ 532.9million. The primary driver of the GAAP decrease was a non-cash goodwill impairment of $ 215.0million in the fourth quarter of 2024 related to the Biologics Solutions reporting unit. (5) While this number was reported as $4,743,481 in the 2024 proxy statement, we are updating to $ 4,767,341to reflect a corrected, accurate calculation. Reconciliation of Summary Compensation Table Total to Compensation Actually Paid The table below details the adjustments made to the total compensation paid as disclosed in the Summary Compensation to arrive at the compensation actually paid for our CEO and the average for our other named executives:**

| ​ | ​                     | Year | ​ | ​ | ​ | Executive(s) |         ​ | ​ | ​ | SCT Total |